In Vitro Evaluation of the Activity of Terpenes and Cannabidiol against Human Coronavirus E229.

CBD COVID-19 HCoV-229E antiviral cannabis terpenes

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
29 Mar 2021
Historique:
received: 03 03 2021
revised: 22 03 2021
accepted: 23 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 4 4 2021
Statut: epublish

Résumé

The activity of a new, terpene-based formulation, code-named NT-VRL-1, against Human Coronavirus (HCoV) strain 229E was evaluated in human lung fibroblasts (MRC-5 cells), with and without the addition of cannabidiol (CBD). The main constituents in the terpene formulation used for the experiment were beta caryophyllene, eucalyptol, and citral. The tested formulation exhibited an antiviral effect when it was pre-incubated with the host cells prior to virus infection. The combination of NT-VRL-1 with CBD potentiated the antiviral effect better than the positive controls pyrazofurin and glycyrrhizin. There was a strong correlation between the quantitative results from a cell-viability assay and the cytopathic effect seen under the microscope after 72 h. To the best of our knowledge, this is the first report of activity of a combination of terpenes and CBD against a coronavirus.

Identifiants

pubmed: 33805385
pii: life11040290
doi: 10.3390/life11040290
pmc: PMC8065867
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Sci Rep. 2021 Jan 14;11(1):1462
pubmed: 33446817
Virology. 2016 Aug;495:18-32
pubmed: 27152479
Viruses. 2012 Jun;4(6):1011-33
pubmed: 22816037
Molecules. 2019 Jul 05;24(13):
pubmed: 31284397
Vet Res. 2018 Jul 31;49(1):76
pubmed: 30060764
Molecules. 2011 Jan 25;16(2):1044-54
pubmed: 21350392
Lancet. 1966 Jan 8;1(7428):76-7
pubmed: 4158999
Phytother Res. 2013 Jan;27(1):1-15
pubmed: 23296806
Molecules. 2020 May 17;25(10):
pubmed: 32429580
Lancet. 2003 Jun 14;361(9374):2045-6
pubmed: 12814717
Virol J. 2020 Sep 9;17(1):136
pubmed: 32907596
J Med Chem. 2005 Feb 24;48(4):1256-9
pubmed: 15715493
Planta Med. 2009 Oct;75(12):1331-5
pubmed: 19347799
Iran J Microbiol. 2014 Jun;6(3):149-55
pubmed: 25870747
Clin Infect Dis. 2003 Oct 1;37(7):929-32
pubmed: 13130404
Chem Biodivers. 2008 Mar;5(3):461-70
pubmed: 18357554
Plant Cell. 1995 Jul;7(7):1015-26
pubmed: 7640522
Phytother Res. 2010 May;24(5):673-9
pubmed: 19653195
Phytomedicine. 2020 Nov;78:153296
pubmed: 32890913
Aging (Albany NY). 2021 Jan 19;13(2):1571-1590
pubmed: 33465050

Auteurs

Lior Chatow (L)

Eybna Technologies Ltd., Givat Hen 43905, Israel.

Adi Nudel (A)

Eybna Technologies Ltd., Givat Hen 43905, Israel.

Iris Nesher (I)

Eybna Technologies Ltd., Givat Hen 43905, Israel.

David Hayo Hemo (D)

Eybna Technologies Ltd., Givat Hen 43905, Israel.

Perri Rozenberg (P)

Eybna Technologies Ltd., Givat Hen 43905, Israel.

Hanna Voropaev (H)

Eybna Technologies Ltd., Givat Hen 43905, Israel.

Ilan Winkler (I)

Eybna Technologies Ltd., Givat Hen 43905, Israel.

Ronnie Levy (R)

Eybna Technologies Ltd., Givat Hen 43905, Israel.

Zohar Kerem (Z)

Eybna Technologies Ltd., Givat Hen 43905, Israel.

Zohara Yaniv (Z)

Eybna Technologies Ltd., Givat Hen 43905, Israel.

Nadav Eyal (N)

Eybna Technologies Ltd., Givat Hen 43905, Israel.

Classifications MeSH